VREX (STOCKS)
Varex Imaging Corporation Common Stock
$10.440000
-0.600000 (-5.43%)
Prev close: $11.040000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Sunny S. Sanyal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $439.95M
- Employees
- 2,300
- P/E (TTM)
- -5.24
- P/B (TTM)
- 0.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q2)
|
$0.21 | $0.21 | -0.0039 | -1.82% |
|
Dec 2025 (Q1)
|
$0.19 | $0.14 | +0.0543 | +40.01% |
|
Sep 2025 (Q4)
|
$0.37 | $0.19 | +0.1838 | +98.71% |
|
Jun 2025 (Q3)
|
$0.18 | $0.04 | +0.1443 | +404.20% |
Financial Statements
| Revenues | $857.50M |
| Benefits Costs and Expenses | $932.60M |
| Cost Of Revenue | $569.80M |
| Costs And Expenses | $932.60M |
| Gross Profit | $287.70M |
| Nonoperating Income/Loss | -$43.80M |
| Operating Expenses | $319.00M |
| Selling, General, and Administrative Expenses | $135.60M |
| Research and Development | $89.50M |
| Operating Income/Loss | -$31.30M |
| Income/Loss Before Equity Method Investments | -$71.40M |
| Income/Loss From Continuing Operations After Tax | -$82.50M |
| Income/Loss From Continuing Operations Before Tax | -$75.10M |
| Income/Loss From Equity Method Investments | -$3.70M |
| Income Tax Expense/Benefit | $7.40M |
| Net Income/Loss | -$82.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $200.00K |
| Net Income/Loss Attributable To Parent | -$82.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$82.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.99 |
| Diluted Earnings Per Share | -$1.99 |
| Basic Average Shares | 83,500,000 |
| Diluted Average Shares | 83,500,000 |
| Assets | $1.09B |
| Current Assets | $625.60M |
| Inventory | $346.70M |
| Other Current Assets | $278.90M |
| Noncurrent Assets | $463.80M |
| Intangible Assets | $13.20M |
| Other Non-current Assets | $450.60M |
| Liabilities | $601.30M |
| Current Liabilities | $195.30M |
| Accounts Payable | $96.40M |
| Other Current Liabilities | $98.90M |
| Noncurrent Liabilities | $406.00M |
| Long-term Debt | $347.60M |
| Other Non-current Liabilities | $58.40M |
| Equity | $488.10M |
| Equity Attributable To Noncontrolling Interest | $13.90M |
| Equity Attributable To Parent | $474.20M |
| Liabilities And Equity | $1.09B |
| Net Cash Flow From Operating Activities | -$2.00M |
| Net Cash Flow From Operating Activities, Continuing | -$2.00M |
| Net Cash Flow From Investing Activities | -$12.20M |
| Net Cash Flow From Investing Activities, Continuing | -$12.20M |
| Net Cash Flow From Financing Activities | -$231.00M |
| Net Cash Flow From Financing Activities, Continuing | -$231.00M |
| Exchange Gains/Losses | $700.00K |
| Net Cash Flow | -$244.50M |
| Net Cash Flow, Continuing | -$245.20M |
| Comprehensive Income/Loss | -$85.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $200.00K |
| Comprehensive Income/Loss Attributable To Parent | -$85.90M |
| Other Comprehensive Income/Loss | -$3.20M |